DataMeds AI, Inc. (MEDS)
0.9606
-0.21
(-17.90%)
USD |
NASDAQ |
Aug 28, 16:00
0.9702
+0.01
(+1.00%)
After-Hours: 20:00
DataMeds AI EPS Diluted (Quarterly) : -7.132 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.132 |
| March 31, 2026 | -3.242 |
| December 31, 2025 | -13.75 |
| September 30, 2025 | -19.18 |
| June 30, 2025 | -5.284 |
| March 31, 2025 | -26.38 |
| December 31, 2024 | -4.170 |
| Date | Value |
|---|---|
| September 30, 2024 | -1.797 |
| June 30, 2024 | -0.553 |
| March 31, 2024 | -0.08 |
| December 31, 2023 | -1.036 |
| September 30, 2023 | -0.8695 |
| June 30, 2023 | -0.4125 |
| March 31, 2023 | -0.469 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | -0.0002 |
| Xcelerate, Inc. | -0.0001 |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.0004 |
| Vivos Therapeutics, Inc. | -0.31 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.36M |
| Revenue (Quarterly) | 1.780M |
| Total Expenses (Quarterly) | 20.14M |
| Enterprise Value | 33.06M |
| Gross Profit Margin (Quarterly) | -9.80% |
| Profit Margin (Quarterly) | -1.03K% |
| Earnings Yield | -4.51K% |
| Normalized Earnings Yield | -3667.95 |